These data provide further support for the hypothesis that increases in the level of IL1 signaling in the AD brain can be detrimental through the cytokine's role as a key component of the neuroinflammatory cascade that contributes to progression of neuropathology. The gene discussed is IL1B; the disease is Alzheimer disease.